PAREXEL International Corporation (PRXL), a global biopharmaceutical services company and provider of clinical research and logistics, recently announced the signing of a definitive agreement to acquire ExecuPharm Inc.
- Accesswire•2 days agoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of PAREXEL Corporation - PRXL
NEW YORK, NY / ACCESSWIRE / September 26, 2016 / Pomerantz LLP is investigating claims on behalf of investors of PAREXEL Corporation ("PAREXEL" or the "Company") (NASDAQ: PRXL). Such ...
- Business Wire•2 days ago
PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc.
PAREXEL International Corporation (PRXL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||70.17 x 200|
|Ask||70.44 x 100|
|Day's Range||70.19 - 70.71|
|52wk Range||56.00 - 71.13|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||24.62|
|Avg Vol (3m)||412,079|
|Dividend & Yield||N/A (N/A)|